Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reade Rheumatology Registry for biologics and targeted synthetic DMARDs
NL-OMON28595Recruiting
- Sponsor
- Reade Rheumatology
- Start
- Nov 2016
- Countries
- 1
01
Overview
Open-label trial in rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS) and 1 more (4 cohorts), sponsored by Reade Rheumatology. Primary endpoints: Efficacy, Patient-reported outcomes and 3 more. Started Nov 2016; status: recruiting.
02
Conditions
rheumatoid arthritis (RA)psoriatic arthritis (PsA)ankylosing spondylitis (AS)non-radiographic axial spondyloarthritis (nr-axSpA)
Beyond the preview
Go deeper on NL-OMON28595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28595.